MA42103A - Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm) - Google Patents

Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm)

Info

Publication number
MA42103A
MA42103A MA042103A MA42103A MA42103A MA 42103 A MA42103 A MA 42103A MA 042103 A MA042103 A MA 042103A MA 42103 A MA42103 A MA 42103A MA 42103 A MA42103 A MA 42103A
Authority
MA
Morocco
Prior art keywords
rpm
receptor modulator
progesterone receptor
dosage regime
selective progesterone
Prior art date
Application number
MA042103A
Other languages
English (en)
Inventor
Rudolf Knauthe
Christian Seitz
Susan Zeun
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53180494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA42103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MA42103A publication Critical patent/MA42103A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA042103A 2015-05-18 2016-05-17 Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm) MA42103A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15001475 2015-05-18

Publications (1)

Publication Number Publication Date
MA42103A true MA42103A (fr) 2018-03-28

Family

ID=53180494

Family Applications (2)

Application Number Title Priority Date Filing Date
MA042103A MA42103A (fr) 2015-05-18 2016-05-17 Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm)
MA046298A MA46298A (fr) 2015-05-18 2016-05-17 Modulateur sélectif du récepteur de la progestérone (sprm) pour son utilisation dans le traitement des saignements menstruels abondants

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA046298A MA46298A (fr) 2015-05-18 2016-05-17 Modulateur sélectif du récepteur de la progestérone (sprm) pour son utilisation dans le traitement des saignements menstruels abondants

Country Status (19)

Country Link
US (3) US20180155388A1 (fr)
EP (2) EP3297635A1 (fr)
JP (2) JP2018515551A (fr)
KR (1) KR20180004814A (fr)
CN (2) CN113797210A (fr)
AU (1) AU2016262826A1 (fr)
BR (1) BR112017024627A2 (fr)
CA (1) CA2986064A1 (fr)
CL (1) CL2017002920A1 (fr)
EA (2) EA035567B1 (fr)
HK (1) HK1245118A1 (fr)
IL (1) IL255451A0 (fr)
MA (2) MA42103A (fr)
MX (1) MX2017014844A (fr)
PH (1) PH12017502100A1 (fr)
SG (1) SG10201910441PA (fr)
TN (1) TN2017000482A1 (fr)
TW (1) TW201707708A (fr)
WO (1) WO2016184863A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017014844A (es) * 2015-05-18 2018-02-19 Bayer Pharma AG Regimen modulador selectivo de los receptores de progesterona (sprm).
EP3214092A1 (fr) * 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Promédicaments du modulateur du récepteur de progesterone (sprm) (11.bêta.,17.bêta.)-17-hydroxy-11-[4-(méthylsulphonyle)phenyle]-17-(pentafluoroéthyl)estra-4,9-dièn-3-one
EP3384913A1 (fr) * 2017-04-03 2018-10-10 Bayer Pharma Aktiengesellschaft Modulateurs sélectifs du récepteur de la progestérone et niveau d' strogène stabilisé chez un patient
US20210171568A1 (en) * 2017-10-26 2021-06-10 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystalline forms of selective progesterone receptor modulator, processes for preparation thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
JP2001520820A (ja) * 1997-02-03 2001-10-30 エムシーアイ・ワールドコム・インコーポレーテッド 通信システム構造
DE19706061A1 (de) 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
PT1899378E (pt) 2005-06-21 2010-01-26 Xoma Technology Ltd Anticorpos de ligação de il-1β e os seus fragmentos
ES2586741T3 (es) 2008-04-30 2016-10-18 Telefonaktiebolaget L M Ericsson (Publ) Red de auto-retorno en LTE
EP2123279A1 (fr) * 2008-05-14 2009-11-25 Bayer Schering Pharma Aktiengesellschaft Administration séquentielle de 20,20,21,21,21-Ppentafluor-17-hydroxy-1 1bêta-[4-(hydroxyacétyl) phényl]-19-nor-17alpha-pregna-4,9-dien-3-on et un ou plusieurs gestagènes destinés au traitement de maladies gynécologiques
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
ES2672509T3 (es) * 2012-09-28 2018-06-14 Aska Pharmaceutical Co., Ltd. Forma polimórfica cristalina de acetato de ulipristal
EP2914268B1 (fr) * 2012-11-02 2018-07-04 Repros Therapeutics Inc. Procédés et compositions pour traiter des états dépendants de la progestérone
KR20140077499A (ko) * 2012-12-14 2014-06-24 에스케이하이닉스 주식회사 저항 변화 메모리 장치 및 그 제조방법
NZ712984A (en) * 2013-04-10 2020-07-31 Preglem Sa Progesteron receptor modulators for use in the therapy of uterine fibroids
US20160296534A1 (en) * 2013-04-11 2016-10-13 Bayer Pharma Aktiengesellschaft Progesterone receptor antagonist dosage form
MX2017014844A (es) 2015-05-18 2018-02-19 Bayer Pharma AG Regimen modulador selectivo de los receptores de progesterona (sprm).
EP3384913A1 (fr) * 2017-04-03 2018-10-10 Bayer Pharma Aktiengesellschaft Modulateurs sélectifs du récepteur de la progestérone et niveau d' strogène stabilisé chez un patient

Also Published As

Publication number Publication date
CN113797210A (zh) 2021-12-17
EA035567B1 (ru) 2020-07-08
CA2986064A1 (fr) 2016-11-24
EA201792524A1 (ru) 2018-04-30
WO2016184863A1 (fr) 2016-11-24
IL255451A0 (en) 2017-12-31
AU2016262826A1 (en) 2017-11-30
EP3297635A1 (fr) 2018-03-28
JP2021098702A (ja) 2021-07-01
HK1245118A1 (zh) 2018-08-24
TW201707708A (zh) 2017-03-01
US20180155388A1 (en) 2018-06-07
MA46298A (fr) 2019-07-31
US20190375783A1 (en) 2019-12-12
KR20180004814A (ko) 2018-01-12
TN2017000482A1 (en) 2019-04-12
MX2017014844A (es) 2018-02-19
PH12017502100A1 (en) 2018-05-07
SG10201910441PA (en) 2020-01-30
EP3417863A1 (fr) 2018-12-26
EA036237B1 (ru) 2020-10-16
US10858388B2 (en) 2020-12-08
CN107635562A (zh) 2018-01-26
US20190211053A1 (en) 2019-07-11
EA201990106A1 (ru) 2019-05-31
JP2018515551A (ja) 2018-06-14
BR112017024627A2 (pt) 2018-07-31
CL2017002920A1 (es) 2018-05-18

Similar Documents

Publication Publication Date Title
DK3283110T3 (da) Antistoffer rettet mod interleukin-36-receptor (il-36r)
DK3274366T3 (da) Kimær antigenreceptor
MA43382A (fr) Modulateurs des récepteurs des chimiokines
DK3341465T3 (da) Perfusionsfordeleranordning
DK3346961T3 (da) Anordning til stomi
DK3139986T3 (da) System til administration af terapeutisk gas
DK3368060T3 (da) Glugacon-receptor-agonister
DK3280368T3 (da) Stomianordning
DK3256125T3 (da) Doseringsregimen for ponesimod, en selektiv s1p1-receptoragonist
DK3310414T3 (da) Lægemiddeladministrationsanordning
DK3386500T3 (da) Benzothiophen-baserede selektive østrogenreceptor ned-regulatorer
DK3268067T3 (da) Lægemiddeladministrationsanordning
DK3099356T3 (da) Medikamentadministrationsanordning
DK3490986T3 (da) Piperidin-cxcr7-receptormodulatorer
BR112017024750A2 (pt) dispositivo de cofragem
DK3380139T3 (da) Medikamentadministrationsanordning
DK3380146T3 (da) Medikamentadministrationsanordning
DE102015120393A8 (de) Lendenstützvorrichtung
MA41139A (fr) Combinaison pharmaceutique comportant un agoniste sélectif du récepteur sip1
MA52555A (fr) Modulateurs du récepteur des oestrogènes
MA42103A (fr) Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm)
DK3347349T3 (da) Fluorindolderivater som muskarin m1-receptor-positive allosteriske modulatorer
DK3349825T3 (da) Lægemiddeladministrationsanordning
DK3356091T3 (da) Ledindretning
DE112016001035A5 (de) Halterungsvorrichtung